These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 17945474)

  • 1. Formation and physical stability of the amorphous phase of ranitidine hydrochloride polymorphs prepared by cryo-milling.
    Chieng N; Rades T; Saville D
    Eur J Pharm Biopharm; 2008 Mar; 68(3):771-80. PubMed ID: 17945474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
    Chieng N; Aaltonen J; Saville D; Rades T
    Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of milling conditions on the solid-state conversion of ranitidine hydrochloride form 1.
    Chieng N; Zujovic Z; Bowmaker G; Rades T; Saville D
    Int J Pharm; 2006 Dec; 327(1-2):36-44. PubMed ID: 16949221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative solid-state analysis of three solid forms of ranitidine hydrochloride in ternary mixtures using Raman spectroscopy and X-ray powder diffraction.
    Chieng N; Rehder S; Saville D; Rades T; Aaltonen J
    J Pharm Biomed Anal; 2009 Jan; 49(1):18-25. PubMed ID: 19081220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward understanding the evolution of griseofulvin crystal structure to a mesophase after cryogenic milling.
    Feng T; Bates S; Carvajal MT
    Int J Pharm; 2009 Feb; 367(1-2):16-9. PubMed ID: 19013224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation, physical stability, and quantification of process-induced disorder in cryomilled samples of a model polymorphic drug.
    Hu Y; Macfhionnghaile P; Caron V; Tajber L; Healy AM; Erxleben A; McArdle P
    J Pharm Sci; 2013 Jan; 102(1):93-103. PubMed ID: 23047833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of particle size and preparation methods on the physical and chemical stability of amorphous simvastatin.
    Zhang F; Aaltonen J; Tian F; Saville DJ; Rades T
    Eur J Pharm Biopharm; 2009 Jan; 71(1):64-70. PubMed ID: 18703139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of polymorphic forms of ranitidine hydrochloride.
    Wu V; Rades T; Saville DJ
    Pharmazie; 2000 Jul; 55(7):508-12. PubMed ID: 10944778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methods.
    Karmwar P; Graeser K; Gordon KC; Strachan CJ; Rades T
    Int J Pharm; 2011 Sep; 417(1-2):94-100. PubMed ID: 21182910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds.
    Patterson JE; James MB; Forster AH; Lancaster RW; Butler JM; Rades T
    J Pharm Sci; 2005 Sep; 94(9):1998-2012. PubMed ID: 16052554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of crystalline disorder in cryo-milled samples of indomethacin using atomic pair-wise distribution functions.
    Bøtker JP; Karmwar P; Strachan CJ; Cornett C; Tian F; Zujovic Z; Rantanen J; Rades T
    Int J Pharm; 2011 Sep; 417(1-2):112-9. PubMed ID: 21182911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphic form of piroxicam influences the performance of amorphous material prepared by ball-milling.
    Naelapää K; Boetker JP; Veski P; Rantanen J; Rades T; Kogermann K
    Int J Pharm; 2012 Jun; 429(1-2):69-77. PubMed ID: 22433471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-ray powder diffractometry in combination with principal component analysis--a tool for monitoring solid state changes.
    Kogermann K; Veski P; Rantanen J; Naelapää K
    Eur J Pharm Sci; 2011 Jul; 43(4):278-89. PubMed ID: 21575718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The development of co-amorphous drug systems].
    Yao J; Shi NQ; Wang XL
    Yao Xue Xue Bao; 2013 May; 48(5):648-54. PubMed ID: 23888685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigations on the effect of different cooling rates on the stability of amorphous indomethacin.
    Karmwar P; Boetker JP; Graeser KA; Strachan CJ; Rantanen J; Rades T
    Eur J Pharm Sci; 2011 Oct; 44(3):341-50. PubMed ID: 21884789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of physical properties and stability of indomethacin-cimetidine and naproxen-cimetidine co-amorphous systems prepared by quench cooling, coprecipitation and ball milling.
    Lim AW; Löbmann K; Grohganz H; Rades T; Chieng N
    J Pharm Pharmacol; 2016 Jan; 68(1):36-45. PubMed ID: 26663364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of calcined Mg-Al-hydrotalcite to enhance the stability of celecoxib in the amorphous form.
    Ambrogi V; Perioli L; Marmottini F; Rossi C
    Eur J Pharm Biopharm; 2007 May; 66(2):253-9. PubMed ID: 17123798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amorphization of different furosemide polymorphic forms during ball milling: Tracking solid-to-solid phase transformations.
    Wang M; Gong J; Rades T; Martins ICB
    Int J Pharm; 2023 Dec; 648():123573. PubMed ID: 37931725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of different preparation methods on the dissolution behaviour of amorphous indomethacin.
    Karmwar P; Graeser K; Gordon KC; Strachan CJ; Rades T
    Eur J Pharm Biopharm; 2012 Feb; 80(2):459-64. PubMed ID: 22019529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of crystal morphology and mill type on milling induced crystal disorder.
    Chikhalia V; Forbes RT; Storey RA; Ticehurst M
    Eur J Pharm Sci; 2006 Jan; 27(1):19-26. PubMed ID: 16246535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.